Odyssey Health (ODYY) Net Income towards Common Stockholders Growth (3y) (2017 - 2026)
Odyssey Health (ODYY) Net Income towards Common Stockholders Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 64.73% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 60.12% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 29.56% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 31.01% |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | 37.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 37.44% |
| Jan 31, 2026 | 29.16% |
| Oct 31, 2025 | 42.97% |
| Jul 31, 2025 | 40.17% |
| Apr 30, 2025 | 56.69% |
| Jan 31, 2025 | 53.47% |
| Oct 31, 2024 | 26.71% |
| Jul 31, 2024 | -70.33% |
| Apr 30, 2024 | 59.25% |
| Jan 31, 2024 | 158.14% |
| Oct 31, 2023 | 8.89% |
| Jul 31, 2023 | 20.29% |
| Apr 30, 2023 | 52.79% |
| Jan 31, 2023 | 48.70% |
| Oct 31, 2022 | 13.77% |
| Jul 31, 2022 | 63.22% |
| Apr 30, 2022 | -266.86% |
| Jan 31, 2022 | -173.77% |
| Oct 31, 2021 | -187.20% |
| Jul 31, 2021 | -196.50% |